Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$549

Avg closing price
Price range

13 Ken Griffin Biolase Trades

The first Biolase trade was made in Q2 2018. Since then Ken Griffin bought shares six more times and sold shares on six occasions. The investor completely sold their stake between Q3 2022 and Q4 2022.

Avg closing price
Price range
Sold -175 shares Q4 2022
Avg closing price $143.91
Price range $59.00 - $250.00
Sold 31.9% shares (-82 shares) Q3 2022
Avg closing price $399.70
Price range $243.00 - $553.25
New holding (+258 shares) Q2 2022
Avg closing price $549.22
Price range $342.00 - $875.25
Sold -35 shares Q4 2021
Avg closing price $1,261.24
Price range $952.50 - $1,572.50
Increased shares by 337.5% (+27 shares) Q3 2021
Avg closing price $1,632.49
Price range $1,394.00 - $1,974.75
Sold 94.8% shares (-146 shares) Q2 2021
Avg closing price $1,856.04
Price range $1,450.00 - $2,550.00
Increased shares by 118.3% (+84 shares) Q1 2021
Avg closing price $2,457.56
Price range $1,175.00 - $3,750.00
Increased shares by 1320.0% (+66 shares) Q3 2020
Avg closing price $937.57
Price range $667.00 - $1,275.00
New holding (+5 shares) Q2 2020
Avg closing price $1,138.65
Price range $575.00 - $2,010.00
Sold -5 shares Q1 2019
Avg closing price $4,856.95
Price range $2,586.25 - $6,950.00
New holding (+5 shares) Q4 2018
Avg closing price $3,228.52
Price range $2,300.00 - $5,325.00
Sold -4 shares Q3 2018
Avg closing price $4,000.39
Price range $2,950.00 - $5,500.00
New holding (+4 shares) Q2 2018
Avg closing price $3,766.19
Price range $2,900.00 - $5,212.50

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!